The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure

Cardiovascular Ultrasound

Volumn 9, Issue 1, 2011, Pages

  Hlebowicz, Joanna ^a   Lindstedt, Sandra ^a   Björgell, Ola ^a   Dencker, Magnus ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FOOD INTAKE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HORMONE RELEASE; HUMAN; MALE; NORMAL HUMAN; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; EATING; GLUCOSE BLOOD LEVEL; HEART FUNCTION TEST; HEMODYNAMICS; METABOLISM; PHYSIOLOGY; POSTPRANDIAL STATE; REPRODUCIBILITY; STANDARD; SYSTOLE; VALIDATION STUDY;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIAC OUTPUT; DIASTOLE; EATING; ECHOCARDIOGRAPHY, DOPPLER; FASTING; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HEART FUNCTION TESTS; HEART RATE; HEMODYNAMICS; HUMANS; INSULIN; MALE; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; SYSTOLE;

EID: 84855171929     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-9-43     Document Type: Article

References (51)

1. The effect of meal size on postprandial increase in cardiac output. Waaler BA, Eriksen M, Toska K, Acta Physiol Scand 1991 142 1 33 39 10.1111/j.1748-1716.1991.tb09125.x 1877363
2. Post-prandial cardiovascular responses in man after ingestion of carbohydrate, protein or fat. Waaler BA, Eriksen M, Acta Physiol Scand 1992 146 3 321 327 10.1111/j.1748-1716.1992.tb09426.x 1481689
3. Postprandial alterations in hemodynamics and blood pressure in normal subjects. Fagan TC, Sawyer PR, Gourley LA, Lee JT, Gaffney TE, Am J Cardiol 1986 58 636 641 10.1016/0002-9149(86)90291-2 3751935 (Pubitemid 16023535)
4. Circulatory responses to a meal in patients with a newly transplanted heart. Waaler BA, Hisdal J, Eriksen M, Acta Physiol Scand 2002 174 101 108 10.1046/j.1365-201X.2002.00934.x 11860371 (Pubitemid 34226957)
5. Relationship between postprandial changes in cardiac left ventricular function, glucose and insulin concentrations, gastric emptying, and satiety in healthy subjects. Hlebowicz J, Lindstedt S, Björgell O, Dencker M, Nutr J 2011 10 26 10.1186/1475-2891-10-26 21429209
6. Normal and disturbed motility of the gastrointestinal tract. Smout AJMP, Akkermans LMA, Wrightson Biomedical Publishing LTD Petersfield 1992
7. Gastric motility and emptying in normal and post-vagotomy subjects. Sheiner HJ, Quinlan MF, Thompson IJ, Gut 1980 21 9 753 759 10.1136/gut.21.9.753 7429340 (Pubitemid 11209221)
8. Mechanisms behind the postprandial increase in cardiac output: a clue obtained from transplanted hearts. Waaler BA, Hisdal J, Ihlen H, Kjekshus J, Eur J Appl Physiol 2006 97 516 520 10.1007/s00421-006-0210-0 16718506
9. Hemodynamic actions of insulin. Baron AD, Am J Physiol 1994 267 187 202 8074198
10. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP, Circulation 2004 109 8 962 925 10.1161/01.CIR.0000120505.91348.58 14981009 (Pubitemid 38282847)
11. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP, J Card Fail 2006 212 9 694 699 (Pubitemid 44881367)
12. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K, Am J Physiol Regul Integr Comp Physiol 2010 280 5 1483 1487
13. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. Nagaya N, Miyatake K, Uematsu M, Oya H, Shimizu W, Hosoda H, Kojima M, Nakanishi N, Mori H, Kangawa K, J Clin Endocrinol Metab 2010 86 12 5854 5859
14. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K, Circulation 2004 110 24 3674 3679 10.1161/01.CIR.0000149746.62908. BB 15569841 (Pubitemid 39665256)
15. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K, Circulation 2004 109 8 962 965 10.1161/01.CIR.0000120505. 91348.58 14981009 (Pubitemid 38282847)
16. The effects of insulin induced hypoglycemia on cardiovascular function in normal man: studies using radionuclide ventriculography. Fisher BM, Gillen G, Dargie HJ, Inglis GC, Frier BM, Diabetologia 1987 30 841 845 3328719 (Pubitemid 18003664)
17. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Packer M, Medina N, Yushak M, Circulation 1985 71 761 766 10.1161/01.CIR.71.4.761 3971544 (Pubitemid 15099127)
18. Measurement of gastric emptying by standardized real-time ultrasonography in healthy subjects and diabetic patients. Darwiche G, Almér LO, Björgell O, Cederholm C, Nilsson P, J Ultrasound Med 1999 18 10 673 682 10511299
19. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Quĩones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, J Am Soc Echocardiogr 2002 15 2 167 184 10.1067/mje.2002.120202 11836492
20. Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. rskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ, Diabetes 1994 43 535 539 10.2337/diabetes.43.4.535 8138058
21. Glucagon-like peptide-1 under-goes differential tissue-specific metabolism in the anaesthetised pig. Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ, Am J Physiol 1996 271 458 464 8843738
22. Haemodynamics of the pressor effect of oral water in human sympathetic denervation due to autonomic failure. Cariga P, Mathias CJ, Clin Sci (Lond) 2001 101 3 313 319 10.1042/CS20000253 (Pubitemid 32835529)
23. The pressor response to water drinking in humans: a sympathetic reflex? Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, Robertson D, Circulation 2002 101 5 504 509
24. A potent pressor response elicited by drinking water. Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D, Lancet 1999 353 9154 723 10.1016/S0140-6736(99)99015-3 10073520 (Pubitemid 29103811)
25. Gastric distension attenuates the hypotensive effect of intraduodenal glucose in healthy older subjects. Gentilcore D, Meyer JH, Rayner CK, Horowitz M, Jones C, Am J Physiol Regul Integr Comp Physiol 2008 295 2 472 477 10.1152/ajpregu.00108.2008 18495838
26. Effect of gastric distension on cardiovascular parameters: gastrovascular reflex is attenuated in the elderly. van Orshoven NP, Oey PL, van Schelven LJ, Roelofs JM, Jansen PA, Akkermans LM, J Physiol 2004 555 Pt 2 573 583 14724212 (Pubitemid 38380012)
27. Central haemodynamic changes after a meal. Kelbaek H, Muck O, Christensen NJ, Godtfredsen J, Br Heart J 1990 61 506 559
28. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Baron AD, Brechtel G, Am J Physiol 1993 265 61 67 8338155
29. Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med Wochenschr. Regitz-Zagrosek V, Seeland U, 2011 161 5-6 109 116
30. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. Halbirk M, Nørrelund H, Møller N, Holst JJ, Schmitz O, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjaer H, Bøtker HE, Wiggers H, Am J Physiol Heart Circ Physiol 2010 298 3 1096 1102 10.1152/ajpheart.00930. 2009 20081109
31. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. Griffioen KJ, Wan R, Okun E, Wang X, Lovett-Barr MR, Li Y, Mughal MR, Mendelowitz D, Mattson MP, Cardiovasc Res 2001 89 1 72 78
32. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. Barragán JM, Rodríguez RE, Blázquez E, Am J Physiol 1994 266 3 Pt 1 459 466 8166268
33. Cardiovascular and pancreatic endocrine responses to glucagon-like peptide-1(7-36) amide in the conscious calf. Edwards CM, Edwards AV, Bloom SR, Exp Physiol 1997 82 4 709 716 9257113 (Pubitemid 27363855)
34. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Nyström T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrén B, Sjöholm A, Am J Physiol Endocrinol Metab 2004 287 6 1209 1215 10.1152/ajpendo.00237.2004 15353407 (Pubitemid 39491964)
35. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Vila Petroff MG, Egan JM, Wang X, Sollott SJ, Circ Res 2001 89 5 445 452 10.1161/hh1701.095716 11532906 (Pubitemid 34132661)
36. Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database. Best JH, Hoogwerf BJ, Herman WH, Pelletier EM, Smith DB, Wenten M, Hussein MA, Diabetes Care 2011 34 1 90 905 10.2337/dc10-1393 20929995
37. Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study. Gill A, Hoogwerf BJ, Burger J, Bruce S, Macconell L, Yan P, Braun D, Giaconia J, Malone J, Cardiovasc Diabetol 2010 9 6 10.1186/1475-2840-9-6 20109208
38. Ghrelin and cardiovascular health. García EA, Korbonits M, Curr Opin Pharmacol 2006 6 2 142 147 10.1016/j.coph.2005.10.006 16483844 (Pubitemid 43362127)
39. Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Bella JN, Palmieri V, Roman MJ, Paranicas MF, Welty TK, Lee ET, Fabsitz RR, Howard BV, Devereux RB, Am J Cardiol 2006 98 6 834 837 10.1016/j.amjcard.2006.03.069 16950198 (Pubitemid 44301023)
40. Left ventricular function in men and women: another difference between sexes. Buonanno C, Arbustini E, Rossi L, Dander B, Vassanelli C, Paris B, Poppi A, Eur Heart J 1982 3 6 525 528 7160390 (Pubitemid 13221159)
41. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Rodeheffer RJ, Cowan LD, Howard BV, Am Heart J 2001 141 3 439 446 10.1067/mhj.2001.113223 11231443 (Pubitemid 32200274)
42. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, Canham RM, Levine BD, Drazner MH, Circulation 2006 113 12 1597 1604 10.1161/CIRCULATIONAHA.105. 574400 16567580 (Pubitemid 43739419)
43. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy. Gerdts E, Zabalgoitia M, Bjornstad H, Svendsen TL, Devereux RB, Am J Cardiol 2001 87 980 983 10.1016/S0002-9149(01)01433-3 11305990 (Pubitemid 32299983)
44. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Luchner A, Bröckel U, Muscholl M, Hense HW, Döring A, Riegger GA, Schunkert H, Cardiovasc Re 2002 53 3 720 727 10.1016/S0008-6363(01)00510-7 (Pubitemid 34175264)
45. Echocardiographic left ventricular systolic function and volumes in young adults: distribution and factors influencing variability. Wong ND, Gardin JM, Kurosaki T, Anton-Culver H, Sidney S, Roseman J, Gidding S, Am Heart J 1995 129 3 571 577 10.1016/0002-8703(95)90287-2 7872189
46. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. Bonnemeier H, Richardt G, Potratz J, Wiegand UK, Brandes A, Kluge N, Katus HA, J Cardiovasc Electrophysiol 2003 14 8 791 799 10.1046/j.1540-8167.2003.03078.x 12890036 (Pubitemid 36994094)
47. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Ramaekers D, Ector H, Aubert AE, Rubens A, Van de Werf F, Eur Heart J 1998 19 9 1334 1341 10.1053/euhj.1998.1084 9792258 (Pubitemid 28427134)
48. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. Umetani K, Singer DH, McCraty R, Atkinson M, J Am Coll Cardiol 1998 31 3 593 601 10.1016/S0735-1097(97)00554-8 9502641 (Pubitemid 28144127)
49. Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. Evans JM, Ziegler MG, Patwardhan AR, Ott JB, Kim CS, Leonelli FM, Knapp CF, J Appl Physiol 2001 91 6 2611 2618 11717226 (Pubitemid 33108025)
50. Skipping breakfast: gender effects on resting heart rate measures in preadolescents. Pivik RT, Dykman RA, Tennal K, Gu Y, Physiol Behav 2006 89 2 270 280 10.1016/j.physbeh.2006.06.001 16843505 (Pubitemid 44269358)
51. Autonomic and hemodynamic responses to insulin in lean and obese humans. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, Baldi S, Carpeggiani C, Ferrannini E, J Clin Endocrinol Metab 1998 83 6 2084 2090 10.1210/jc.83.6.2084 9626143 (Pubitemid 28496341)